Patient Access Programs (PAPs) help a company in addressing affordability challenges, especially in the self-pay markets or OOP (out-of-pocket) segment of reimbursed markets, through reducing treatment costs, increasing ability to pay and working with healthcare system partners to operationalise the program. PAPs are increasingly being considered by the companies, as they seek their future growth from the emerging markets, which are typically resource constrained. Additionally, several of the innovative therapies come with a high price-tag, that doesn’t help these healthcare systems and the patients, majority of whom are already from the mid to low affordable segment. ANSEA has developed a robust approach towards conceptualizing, designing, and implementing various PAPs as part of our strategic framework for Market Access. This document provides some considerations for companies that wish to embark on this journey.
- info@anseaconsulting.com
- Singapore: +65 6956 6164
- Basel: +41 61 564 1420